Using Septic Marker to Detect Bacterial Infection in Preterm Infants: New Method
DOI:
https://doi.org/10.61841/rq7k4b09Keywords:
Cytokine, Infection, Sepsis, Diagnosis, Preterm InfantsAbstract
Opportunistic infections, in combination with excessive affliction or death, lead of children not suited to mimic their immune systems. Biomarkers have been proposed within the gore according to neonatal microbial contamination perception. However, the continuous blood tests do make iatrogenic anemia for premature babies. Thus, the study aims to align with the selection of cytokines among saliva, which aid in compliance with early diagnosis of bacterial contamination in children by a non-invasive method. Many of the brawny markers (acute segment reactants, phone floor markers, or cytokines) are not mechanically accessible in conformity with the laboratory, yet mixtures of markers will in all likelihood ascertain increased diagnostic accuracy. In the future, molecular biology techniques offer a possibility to rapidly identify both pathogens and markers of antimicrobial resistance. This nonsurgical method may assist us in the accurate diagnosis of bacterial infections in the premature Neonate.
Downloads
References
[1] A. Prosser et al., “Phagocytosis of neonatal pathogens by peripheral blood neutrophils and monocytes from newborn preterm and term infants,” Pediatr. Res., 2013.
[2] E. M. Mccall, F. Alderdice, H. L. Halliday, S. Vohra, and L. Johnston, “Interventions to prevent hypothermia at birth in preterm and/or low birth weight infants,” Cochrane Database of Systematic Reviews. 2018.
[3] A. A. M. Da Silva et al., “A protocol to identify non-classical risk factors for preterm births: The Brazilian Ribeirão Preto and São Luís prenatal cohort (Brisa),” Reprod. Health, 2014.
[4] M. R. Bentlin and L. M. S. de Souza Rugolo, “Late-onset sepsis: Epidemiology, evaluation, and outcome,”
Neoreviews, 2010.
[5] M. Y. Lai et al., “Characteristics of neonates with culture-proven bloodstream infection who have low levels of C-reactive protein (≦10 mg/L),” BMC Infect. Dis., 2015.
[6] I. L. Chen, H. C. Huang, M. C. Ou-Yang, F. S. Chen, M. Y. Chung, and C. C. Chen, “A novel method to detect bacterial infection in premature infants: Using a combination of inflammatory markers in blood and saliva,” J. Microbiol. Immunol. Infect., 2019.
[7] V. Ronzino-Dubost et al., “Evaluation of the interest of procalcitonin in the diagnosis of chorioamnionitis in preterm premature rupture of membranes. An observational and prospective study,” J. Gynecol. Obstet. Biol. la Reprod., 2016.
[8] I. Z., “Diagnosis of neonatal sepsis: What the clinician expects, what the laboratory tells,” Clin. Biochem., 2014.
[9] G. A., M. M., M. Y., F. M., and P. S., “Monitoring of septic-inflammatory marker trend in VV-ECMO septic patientsno,” Eur. Hear. J. Acute Cardiovasc. Care, 2019.
[10] S. Saito, S. Yoneda, and N. Yoneda, “To detect intrauterine inflammation and to evaluate intra-amniotic infection predict the prognosis of preterm labor cases,” Am. J. Reprod. Immunol., 2011.
[11] S. J. Kim, S. O. Hwang, Y. W. Kim, J. H. Lee, and K. C. Cha, “Procalcitonin as a diagnostic marker for sepsis/septic shock in the emergency department; a study based on Sepsis-3 definition,” Am. J. Emerg. Med., 2019.
[12] D. Pagliaccia et al., “A pathogen secreted protein as a detection marker for citrus huanglongbing,” Front. Microbiol., 2017.
[13] V. Sargentini et al., “Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study,” Clin. Chem. Lab. Med., 2015.
[14] J. P. Bucci, M. D. Shattuck, S. A. Aytur, R. Carey, and W. H. McDowell, “A case study characterizing animal fecal sources in surface water using a mitochondrial DNA marker,” Environ. Monit. Assess., 2017.
[15] Z. Khurshid, S. Zohaib, S. Najeeb, M. S. Zafar, P. D. Slowey, and K. Almas, “Human saliva collection devices for proteomics: An update,” International Journal of Molecular Sciences. 2016.
[16] K. E. Kaczor-Urbanowicz, C. Martin Carreras-Presas, K. Aro, M. Tu, F. Garcia-Godoy, and D. T. W. Wong, “Saliva diagnostics – Current views and directions,” Experimental Biology and Medicine. 2017.
[17] D. Finco et al., “Cytokine release assays: Current practices and future directions,” Cytokine. 2014.
[18] D. D. Anthony et al., “Dissecting the T Cell Response: Proliferation Assays vs. Cytokine Signatures by ELISPOT,” Cells, 2012.
[19] J. A. Stenken and A. J. Poschenrieder, “Bioanalytical chemistry of cytokines - A review,” Analytica Chimica Acta. 2015.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
